TNP-470 antiangiogenic therapy for advanced murine neuroblastoma

Journal of Pediatric Surgery

Volumn 32, Issue 2, 1997, Pages 287-293

  Nagabuchi, Eisuke ^b   VanderKolk, Wayne E ^b   Une, Yoshie ^b   Ziegler, Moritz M ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b NONE

Author keywords

anti angiogenesis; Neuroblastoma

Indexed keywords

ANGIOGENESIS INHIBITOR; FUMAGILLOL CHLOROACETYLCARBAMATE;

ADVANCED CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; AXILLARY LYMPH NODE; CANCER INHIBITION; CANCER SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; MOUSE; NEUROBLASTOMA; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 0031048474     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3468(97)90196-2     Document Type: Conference Paper

References (28)

1. Folkman J: Anti-angiogenesis. New concept for therapy of solid tumors. Ann Surg 175:409-416, 1972
2. Ingber D, Fujita T, Kishimoto S, et al: Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 348:555-557, 1990
3. Takamiya Y, Fnedlander RM, Brem H, et al: Inhibition of angiogenesis and growth of human nerve-sheath tumors by AGM-1470. J Neurosurg 78:470-476, 1993
4. Brem H, Folkman J: Analysis of experimental antiangiogenic therapy. J Pediatr Surg 28:445-451, 1993
5. Wilson JT, Penar PL: The effect of AGM-1470 in an improved intracranial 9L gliosarcoma rat model. Neuro Res 16:121-124, 1994
6. Yamaoka M, Yamamoto T, Masaki T, et al: Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470; AGM-1470). Can Res 53:4262-4267, 1993
7. Abrams JS, Moore TD, Friedman M: New chemotherapeutic agents for breast cancer. Cancer 74:1164-1176, 1994
8. O'Reilly MS, Brem H, Folkman J: Treatment of murine hemangio-endotheliomas with the angiogenesis inhibitor AGM-1470. J Pediatr Surg 30:325-330, 1995
9. De Bernardi B, Pianca C, Boni L, et al: Disseminated neuroblastoma (Stage IV and IV-S) in the first year of life. Cancer 70:1625-1633, 1992
10. Garaventa A, De Bernardi B, Pianca C, et al: Localized but unresectable neuroblastoma: Treatment and outcome of 145 cases. J Clin Oncol 11:1770-1779, 1993
11. Ziegler MM, Naito H, McCarrick J, et al: C-1300 murine neuroblastoma. A suitable animal model of human disease, in Brooks B (ed): Malignant Tumors of Childhood. Austin, TX, University of Texas, 1986, pp 114-126
12. Ishizu H, Bove KE, Ziegler MM, et al: Immune-mediated regression of 'metastatic' neuroblastoma in the liver. J Pediatr Surg 29:155-160, 1994
13. Choi SH, Reynolds JV, Ziegler MM: Systematic analysis of the immunoregulation of murine neuroblastoma. J Pediatr Surg 24:15-20, 1989
14. Nagabuchi E, Kunikane H, Krishan A, et al: In vitro invasiveness in comparison with the expression of MHC-1 antigen in murine neuroblastoma. Proc Am Assoc Cancer Res 35:62, 1994
15. Burrows FJ, Watanabe Y, Thorpe PE: A murine model for antibody-directed targeting of vascular endothelial cells in solid tumors. Can Res 52:5954-5962, 1992
16. Ziegler MM: Immunobiology of neuroblastoma. Pediatr Surg Int 6:2-8, 1991
17. Seeger R, Reynolds C: Neuroblastoma, in Holland J, Frei E, Bast R, et al (eds): Cancer Medicine. Philadelphia, PA, Lea & Febiger, 1993, pp 1472
18. Matthay K, Atkinson J, Stram D, et al: Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: A Childrens Cancer Group pilot study. J Clin Oncol 11:2226-2233, 1993
19. Ladestein R, Favrot M, Lasset C, et al: Indication and limits of megatherapy and bone marrow transplantation. Eur J Cancer 29A:947-954, 1993
20. Nagabuchi E, Ziegler M: Neuroblastoma, in Oldham KT, Foglia RP, Colombani PM, (eds): Surgery of Infants and Children: Scientific Principles and Practice. Philadelphia, PA, Lippincott (in press)
21. Takamiya Y, Brem H, Ojeifo J, et al: AGM-1470 inhibits the growth of human glioblastoma cells in vitro and in vivo. Neurosurg 34:869-875, 1994
22. Nagabuchi E, Ziegler M, Une Y: Inhibition of tumor growth in murine neuroblastoma by TNP-470. Proc Jpn Cancer Assoc 54:591, 1995
23. Kusaka M, Sudo K, Matsutani E. et al: Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470). Br J Can 69:212-216, 1994
24. Teicher BA, Holden SA, Ara G, et al: Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents. Int J Can 57:920-925, 1994
25. Brem H, Gresser I, Grosfeld J, et al: The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis. J Pediatr Surg 28:1253-1257, 1993
26. Toi M, Yamamoto Y, Imazawa T, et al: Antitumor effect of the angiogenesis inhibitor AGM-1470 and its combination effect with tamoxifen in DMBA induced mammary tumors in rats. Int J Oncol 3:525-528, 1993
27. Schoof DD, Obando JA, Cusack JC, Jr, et al: The influence of angiogenesis inhibitor AGM-1470 on immune system status and tumor growth in vitro. Int J Can 55:630-635, 1993
28. Berger AE, Dortch KA, Staite ND, et al: Modulation of T lymphocyte function by the angiogenesis inhibitor AGM-1470. Agents & Actions 39 Spec No: C86-88, 1993